Skip to content
★ Sign in to follow
AP

Andrew Pearlman

Executive
Aevi Genomic Medicine, LLC
Total declarations
21
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (10 ops.)
€998k

Latest filing published 14 Feb 2014 for Aevi Genomic Medicine, LLC, €26k.

Insider track record

Disclosed buys
0
Disclosed sells
10
Signal history

No signal scores available.

Andrew Pearlman: trading record in brief

Andrew Pearlman discloses dealings in Aevi Genomic Medicine, LLC to SEC (Form 4). We count 21 filings; the first trade dates from 11 September 2012 and the latest from 12 February 2014.

No open-market purchase appears, only 10 sales worth €998k. Outside the open market, there are 2 share grants and 9 option exercises. 2014 to date brings no purchases and 6 sales.

Most recently, on 14 February 2014, the filings show an option exercise worth €26k in Aevi Genomic Medicine, LLC. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Andrew Pearlman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations21 total

21 of 21 declarations